European Commission approves Amicus muscle disorder therapy

Amicus Therapeutics

27/03/2023 12:10

March 27 (Reuters) - Amicus Therapeutics Inc  FOLD.O 
said on Monday the European Commission gave marketing
authorization for its therapy to treat Pompe disease, a muscle
disorder.

 (Reporting by Khushi Mandowara in Bengaluru; Editing by Rashmi
Aich)
 ((Khushi.Mandowara@thomsonreuters.com;))